Obesity and the Obesity Paradox

Chronic Coronary Artery Disease: A Companion to Braunwald's Heart Disease

Volumn , Issue , 2018, Pages 270-279

  Lavie, Carl J ^a,b   De Schutter, Alban ^c   Milani, Richard V ^d  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85037706185     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-42880-4.00019-4     Document Type: Chapter

References (80)

1. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014, 311:806-814.
2. Bastien M., Poirier P., Lemieux I., Després J.P. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014, 56:369-381.
3. Lavie CJ, De Schutter A, Parto P, et al. Obesity and prevalence of cardiovascular diseases and prognosis: the obesity paradox updated. Prog Cardiovasc Dis. doi: 10.1016/j.pcad.2016.01.008 [Epub ahead of print].
4. Lavie C.J., McAuley P.A., Church T.S., et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014, 63:1345-1354.
5. Stewart S.T., Cutler D.M. The contribution of behavior change and public health to improved U.S. population health. NBER Working Paper Series October 2014, Working Paper 20631. http://www.nber.org/papers/w20631.
6. Stewart S.T., Cutler D.M. How behavioral changes have affected U.S. population health since 1960. NBER Working Paper Series March 2016, Working Paper 20631. http://www.nber.org/aging%20health/2015no1/w20631.
7. Wilson P.W.F., D'Agostino R.B., Sullivan L., et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham Experience. Arch Intern Med 2002, 162:1867-1872.
8. Gelber R.P., Gaziano J.M., Manson J.E., et al. A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens 2007, 20:370-377.
9. Mokdad A.H., Ford E.S., Bowman B.A., et al. Diabetes trends in the US: 1990-1998. Diabetes Care 2000, 23:1278-1283.
10. Lavie C.J., Milani R.V., O'Keefe J.H. Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction. Am J Med Sci 2011, 341:388-393.
11. Miller M.T., Lavie C.J., White C.J. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J Cardiometab Syndr 2008, 3:162-167.
12. Alexander C.M., Landsman P.B., Teutsch S.M., et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214.
13. Rader D.J. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med 2007, 120:S12-S18.
14. Carr D.B., Utzschneider K.M., Hull R.L., et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004, 53:2087-2094.
15. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925-1932.
16. Hubert H.B., Feinleib M., McNamara P.M., et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968-977.
17. Rabkin S.W., Mathewson F.A., Hsu P.H. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. Am J Cardiol 1977, 39:452-458.
18. Baker A.R., Silva N.F., Quinn D.W., et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006, 5:1.
19. Das S.R., Alexander K.P., Chen A.Y., et al. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-segment elevation myocardial infarction: results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 2011, 58:2642-2650.
20. Lavie C.J., Milani R.V., Ventura H.O. Impact of obesity on outcomes in myocardial infarction: combating the "obesity paradox". J Am Coll Cardiol 2011, 58:2651-2653.
21. Payvar S., Kim S., Rao S.V., et al. In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients: findings from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 2013, 62:692-696.
22. Buschur M.E., Smith D., Share D., et al. The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Cardiol 2013, 62:685-691.
23. Cepeda-Valery B., Chaudhry K., Slipczuk L., et al. Association between obesity and severity of coronary artery disease at the time of acute myocardial infarction: another piece of the puzzle in the "obesity paradox.". Intl J Card 2014, 176:247-249.
24. Cepeda-Valery B., Chaudhry K., Slipczuk L., et al. Association between obesity and infarct size: insight into the obesity paradox. Intl J Card 2013, 167:604-606.
25. Sharma A., Vallakati A., Einstein A.J., et al. Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis. Mayo Clin Proc 2014, 89:1080-1100.
26. Minutello R.M., Chou E.T., Hong M.K., et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol 2004, 93:1229-1232.
27. Powell B.D., Lennon R.J., Lerman A., et al. Association of body mass index with outcome after percutaneous coronary intervention. Am J Cardiol 2003, 91:472-476.
28. Habib R.H., Zacharias A., Schwann T.A., et al. Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis. Ann Thorac Surg 2005, 79:1976-1986.
29. Pan W., Hindler K., Lee V., et al. Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology 2006, 104:441-447.
30. Romero-Corral A., Montori V.M., Somers V.K., et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006, 368:666-678.
31. Wang Z.J., Zhou Y.J., Galper B.Z., et al. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart 2015, 101:1631-1638.
32. Flegal K.M., Kit B.K., Orpana H., Graubard B.L. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013, 309:71-82.
33. Coutinho T., Goel K., Corrêa de Sá D., et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 2011, 57:1877-1886.
34. Coutinho T., Goel K., Corrêa de Sá D., et al. Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol 2013, 61:553-560.
35. Goel K., Lopez-Jimenez F., De Schutter A., et al. Obesity paradox in different populations: evidence and controversies. Future Cardiol 2014, 10:81-91.
36. McAuley P.A., Artero E.G., Sui X., et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc 2012, 87:443-451.
37. De Schutter A., Lavie C.J., Milani R.V. The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease: the obesity paradox. Prog Cardiovasc Dis 2014, 56:401-408.
38. Lavie C.J., De Schutter A., Patel D., et al. Body composition and coronary heart disease mortality: an obesity or a lean paradox?. Mayo Clin Proc 2011, 86:857-864.
39. Lavie C.J., Milani R.V., Artham S.M., et al. The obesity paradox, weight loss, and coronary disease. Am J Med 2009, 122:1106-1114.
40. Lavie C.J., De Schutter A., Patel D.A., et al. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox.". J Am Coll Cardiol 2012, 60:1374-1380.
41. Azimi A., Charlot M.G., Torp-Pedersen C., et al. Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease. Heart 2013, 99:655-660.
42. Lavie C.J., De Schutter A., Milani R.V. Is there an obesity, overweight or lean paradox in coronary heart disease? Getting to the 'fat' of the matter. Heart 2013, 99:596-598.
43. De Schutter A., Lavie C.J., Patel D.A., et al. Relation of body fat categories by Gallagher classification and by continuous variables to mortality in patients with coronary heart disease. Am J Cardiol 2013, 111:657-660.
44. Barry V.W., Baruth M., Beets M.W., et al. Fitness vs. fatness on all-cause mortality: a meta-analysis. Prog Cardiovasc Dis 2014, 56:382-390.
45. Alpert M.A., Lavie C.J., Agrawal H., et al. Cardiac effects of obesity: pathophysiologic, clinical and prognostic consequences-a review. J Cardiopulm Rehabil Prev 2016, 36:1-11.
46. Abudiab M., Aijaz B., Konecny T., et al. Usefulness of function and aerobic capacity based on stress testing to predict outcomes in normal, overweight, and obese patients. Mayo Clin Proc 2013, 88:1427-1434.
47. Kokkinos P., Faselis C., Myers J., et al. Cardiorespiratory fitness and the paradoxical BMI-mortality risk association in male veterans. Mayo Clin Proc 2014, 89:754-762.
48. Swift D.L., Johannsen N.M., Lavie C.J., et al. The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis 2014, 56:441-447.
49. Ades P.A., Savage P.D. Potential benefits of weight loss in coronary heart disease. Prog Cardiovasc Dis 2014, 56:448-456.
50. Menezes A.R., Lavie C.J., Milani R.V., et al. Cardiac rehabilitation in the United States. Prog Cardiovasc Dis 2014, 56:522-529.
51. Menezes A.R., Lavie C.J., Forman D.E., et al. Cardiac rehabilitation in the elderly. Prog Cardiovasc Dis 2014, 57:152-159.
52. Pack Q.R., Rodriguez-Escudero J.P., Thomas R.J., et al. The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis. Mayo Clin Proc 2014, 89:1368-1377.
53. Artero E.G., Lee D.C., Lavie C.J., et al. Effects of muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev 2012, 32:351-358.
54. Lavie CJ, Forman DE, Arena R. Bulking up skeletal muscle to improve heart failure prognosis. JACC Heart Fail. doi: 10.1016/j.jchf.2015.12.005 [Epub ahead of print].
55. Jahangir E., De Schutter A., Lavie C.J. Low weight and overweightness in older adults: risk and clinical management. Prog Cardiovasc Dis 2014, 57:127-133.
56. Ortega F.B., Lavie C.J., Blair S.N. Obesity and cardiovascular disease. Circ Res 2016, 118:1752-1770.
57. Lavie C.J., Arena R., Swift D.L., et al. Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. Circ Res 2015, 117:207-219.
58. Lavie C.J., Arena R., Franklin B.A. Cardiac rehabilitation and healthy life-style interventions: rectifying program deficiencies to improve patient outcomes. J Am Coll Cardiol 2016, 67:13-15.
59. Grace S.L., Bennett S., Ardern C.I., et al. Cardiac rehabilitation series: Canada. Prog Cardiovasc Dis 2014, 56:530-535.
60. McAllister E.J., Dhurandhar N.V., Keith S.W., et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 2009, 49:868-913.
61. Hebert J.R., Allison D.B., Archer E., Lavie C.J., Blair S.N. Scientific decision making, policy decisions, and the obesity pandemic. Mayo Clin Proc 2013, 88:593-604.
62. Church T.S., Thomas D.M., Tudor-Locke C., et al. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS One 2011, 6:e19657.
63. Archer E.R., Shook R.P., Thomas D.M., et al. 45-Year trends in women's use of time and household management energy expenditure. PLoS One 2013, 8:e56620.
64. Swinburn B., Sacks G., Ravussin E. Increased food energy supply is more than sufficient to explain the US epidemic of obesity. Am J Clin Nutr 2009, 90:1453-1456.
65. Katan M.B., Ludwig D.S. Extra calories cause weight gain-but how much?. JAMA 2010, 303:65-66.
66. Westerterp K.R., Plasqui G. Physically active lifestyle does not decrease the risk of fattening. PLoS One 2009, 4:e4745.
67. DiNicolantonio J.J., O'Keefe J.H., Lucan S.C. Added fructose: a principal driver of type 2 diabetes mellitus and its consequences. Mayo Clin Proc 2015, 90:372-381.
68. DiNicolantonio J.J., Lucan S.C., O'Keefe J.H. The evidence for saturated fat and for sugar related to coronary heart disease. Prog Cardiovasc Dis 2016, 58:464-472.
69. Archer E., Lavie C.J., McDonald S.M., et al. Maternal inactivity: 45-year trends in mothers' use of time. Mayo Clin Proc 2013, 88:1368-1377.
70. Archer E. The childhood obesity epidemic as a result of nongenetic evolution: the maternal resources hypothesis. Mayo Clin Proc 2015, 90:77-92.
71. Archer E. In reply- Maternal, paternal, and societal efforts are needed to "cure" child obesity. Mayo Clin Proc 2015, 90:555-557.
72. Lavie C.J., Archer E., Jahangir E. Cardiovascular health and obesity in women: is cardiorespiratory fitness the answer?. J Womens Health 2016, 25:657-658.
73. Kushner R.F. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 2014, 56:465-472.
74. Di Nicolantonio J.J., Chatterjee S., O'Keefe J.H., Meier P. Lorcaserin for the treatment of obesity? A closer look at its side effects. Open Heart 2014, 1:e000173.
75. Gastrointestinal surgery for severe obesity National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992, 55:615S-619S.
76. Vest A.R., Heneghan H.M., Schauer P.R., et al. Surgical management of obesity and the relationship to cardiovascular disease. Circulation 2013, 127:945-959.
77. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292:1724-1737.
78. Sjostrom L., Peltonen M., Jacobson P., et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012, 307:56-65.
79. Dixon J.B., le Roux C.W., Rubino F., et al. Bariatric surgery for type 2 diabetes. Lancet 2012, 379:2300-2311.
80. Pontiroli A.E., Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery: a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 2011, 253:484-487.